Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies
出版年份 2023 全文链接
标题
Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies
作者
关键词
-
出版物
Pharmacological Reports
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-07
DOI
10.1007/s43440-023-00547-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- mGlu2/3 receptor antagonists for depression: overview of underlying mechanisms and clinical development
- (2023) Shigeyuki Chaki et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- The crosstalk between 5-HT2AR and mGluR2 in schizophrenia
- (2023) Somdatta Saha et al. NEUROPHARMACOLOGY
- Role of group II metabotropic glutamate receptors in ketamine's antidepressant actions
- (2023) Anna Onisiforou et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Co-administration in the treatment of depression: deconstructing the Tower of Babel?
- (2023) Koen Demyttenaere et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials
- (2023) Paweł Moćko et al. Biomedicines
- Structure-based discovery of nonhallucinogenic psychedelic analogs
- (2022) Dongmei Cao et al. SCIENCE
- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
- (2022) Guy M. Goodwin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ketamine and the Future of Rapid-Acting Antidepressants
- (2021) Lace M. Riggs et al. Annual Review of Clinical Psychology
- The Role of Central Serotonin Neurons and 5-HT Heteroreceptor Complexes in the Pathophysiology of Depression: A Historical Perspective and Future Prospects
- (2021) Dasiel O. Borroto-Escuela et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice
- (2021) Agnieszka Pałucha-Poniewiera et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Ketamine - a long way from anesthetic to a prototype antidepressant: Review of potential mechanisms of action
- (2021) Bartłomiej Pochwat Psychiatria Polska
- mGlu2/3 receptor antagonism: A mechanism to induce rapid antidepressant effects without ketamine-associated side-effects
- (2020) Jeffrey M. Witkin PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
- (2020) N. L. Mason et al. NEUROPSYCHOPHARMACOLOGY
- Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials
- (2020) Joanna Kryst et al. Pharmacological Reports
- Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants
- (2020) Bashkim Kadriu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine
- (2020) Danilo De Gregorio et al. JOURNAL OF NEUROSCIENCE
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- (2R,6R)-hydroxynorketamine exerts mGlu2receptor-dependent antidepressant actions
- (2019) Panos Zanos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder
- (2019) Joanna Kryst et al. EXPERT OPINION ON PHARMACOTHERAPY
- GABA interneurons are the cellular trigger for ketamine’s rapid antidepressant actions
- (2019) Danielle M. Gerhard et al. JOURNAL OF CLINICAL INVESTIGATION
- Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression
- (2018) Lindsay P. Cameron et al. ACS Chemical Neuroscience
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Understanding CNS effects of deliriant hallucinogenic drugs through experimental animal models
- (2018) Andrey D. Volgin et al. ACS Chemical Neuroscience
- Rapid-Acting Antidepressants
- (2018) Jeffrey M. Witkin et al. CURRENT PHARMACEUTICAL DESIGN
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
- (2017) Robin L Carhart-Harris et al. NEUROPSYCHOPHARMACOLOGY
- mGlu2/3 Receptor Antagonists as Novel Antidepressants
- (2017) Shigeyuki Chaki TRENDS IN PHARMACOLOGICAL SCIENCES
- Ketamine: 50 Years of Modulating the Mind
- (2016) Linda Li et al. Frontiers in Human Neuroscience
- Psychedelics in the treatment of unipolar mood disorders: a systematic review
- (2016) James JH Rucker et al. JOURNAL OF PSYCHOPHARMACOLOGY
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495
- (2016) Karolina Podkowa et al. NEUROPHARMACOLOGY
- Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats
- (2016) Karolina Podkowa et al. PSYCHOPHARMACOLOGY
- Heterodimer-specific signaling
- (2015) Marc Parmentier Nature Chemical Biology
- Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors
- (2015) Andrea Navarria et al. NEUROBIOLOGY OF DISEASE
- Chronic treatment with LY341495 decreases 5-HT2A receptor binding and hallucinogenic effects of LSD in mice
- (2013) José L. Moreno et al. NEUROSCIENCE LETTERS
- Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine produces antidepressant effects in rats: Role of brain-derived neurotrophic factor
- (2012) C.Y. Liu et al. NEUROSCIENCE
- The size and burden of mental disorders and other disorders of the brain in Europe 2010
- (2011) H.U. Wittchen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Signaling pathways underlying the rapid antidepressant actions of ketamine
- (2011) Ronald S. Duman et al. NEUROPHARMACOLOGY
- Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists
- (2011) José L. Moreno et al. NEUROSCIENCE LETTERS
- The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling
- (2011) Stefania Risso Bradley et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Taming the Ketamine Tiger
- (2010) Edward F. Domino ANESTHESIOLOGY
- Transdermal scopolamine for the prevention of postoperative nausea and vomiting: A systematic review and meta-analysis
- (2010) Christian C. Apfel et al. CLINICAL THERAPEUTICS
- Metabotropic glutamate receptors: From the workbench to the bedside
- (2010) F. Nicoletti et al. NEUROPHARMACOLOGY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats
- (2009) Lêda S.B. Garcia et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Human hallucinogen research: guidelines for safety
- (2008) MW Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Microdialysis of GABA and glutamate: Analysis, interpretation and comparison with microsensors
- (2007) Miranda van der Zeyden et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started